Biomerica Competitors
| BMRA Stock | USD 2.34 0.07 2.90% |
Biomerica vs Pheton Holdings Correlation
Very good diversification
The correlation between Biomerica and PTHL is -0.21 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Biomerica and PTHL in the same portfolio, assuming nothing else is changed.
Moving against Biomerica Stock
The current year's Return On Tangible Assets is expected to grow to -0.95. The current year's Return On Capital Employed is expected to grow to -1.33. At present, Biomerica's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 1.3 M, whereas Other Assets are forecasted to decline to about 86.3 K.Biomerica Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Biomerica and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Biomerica and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Biomerica does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Biomerica Stock performing well and Biomerica Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Biomerica's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SSKN | 3.31 | (0.52) | 0.00 | (1.21) | 0.00 | 7.35 | 18.68 | |||
| IINN | 3.23 | (0.36) | 0.00 | (2.00) | 0.00 | 6.86 | 24.08 | |||
| PAVM | 7.45 | 0.10 | 0.02 | 0.09 | 7.76 | 11.52 | 111.24 | |||
| HSCS | 4.18 | 0.19 | 0.04 | 0.21 | 4.93 | 11.07 | 26.18 | |||
| ALZN | 2.81 | (0.31) | 0.00 | (0.54) | 0.00 | 6.12 | 19.67 | |||
| LUCY | 4.81 | (0.57) | 0.00 | (0.25) | 0.00 | 9.70 | 57.39 | |||
| SINT | 3.85 | (0.08) | 0.00 | (0.02) | 0.00 | 9.09 | 32.00 | |||
| CELZ | 3.94 | (0.72) | 0.00 | (0.46) | 0.00 | 8.61 | 23.26 | |||
| LFWD | 4.22 | (0.09) | 0.00 | (0.07) | 0.00 | 10.14 | 34.28 | |||
| PTHL | 5.52 | 0.14 | 0.03 | 0.10 | 6.77 | 6.56 | 136.77 |
Cross Equities Net Income Analysis
Compare Biomerica and related stocks such as STRATA Skin Sciences, Inspira Technologies Oxy, and PAVmed Inc Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SSKN | (2.3 M) | (20.4 M) | (22.7 M) | (25.9 M) | (16 M) | (27.9 M) | (3.3 M) | (21.5 M) | (4 M) | (3.8 M) | (4.4 M) | (2.7 M) | (5.5 M) | (10.8 M) | (10.1 M) | (9.1 M) | (9.5 M) |
| IINN | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (4.6 M) | (7.2 M) | (17 M) | (4 M) | (11.3 M) | (11.1 K) | (9.9 K) | (10.4 K) |
| PAVM | (548.8 K) | (548.8 K) | (548.8 K) | (548.8 K) | (548.8 K) | (1.8 M) | (5.7 M) | (9.5 M) | (18 M) | (15.9 M) | (34.3 M) | (50.3 M) | (89 M) | (64.2 M) | 39.8 M | 35.8 M | 37.6 M |
| HSCS | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (3.8 M) | (2.5 M) | (4.8 M) | (6.4 M) | (6.6 M) | (8.8 M) | (7.9 M) | (8.3 M) |
| ALZN | (69.5 K) | (69.5 K) | (69.5 K) | (69.5 K) | (69.5 K) | (69.5 K) | (1.6 M) | (932 K) | (4.9 M) | (4.4 M) | (5 M) | (12.4 M) | (14.9 M) | (9.9 M) | (4.5 M) | (4.1 M) | (4.3 M) |
| LUCY | (109.4 K) | (109.4 K) | (109.4 K) | (109.4 K) | (109.4 K) | (109.4 K) | (109.4 K) | (109.4 K) | (109.4 K) | (109.4 K) | (768.2 K) | (3.2 M) | (5.7 M) | (6.7 M) | (7.8 M) | (7 M) | (6.6 M) |
| SINT | (23.8 M) | (23.8 M) | (35 M) | (8.3 M) | (32.6 M) | (23.9 M) | (16.6 M) | (9.3 M) | (8.7 M) | (4.8 M) | (7 M) | (9.3 M) | (12 M) | (8.3 M) | (11 M) | (12.7 M) | (13.3 M) |
| CELZ | 1.4 K | (24.1 K) | (25.6 K) | (27.3 K) | (28 K) | (30.8 K) | (766.1 K) | (2.7 M) | (13.7 M) | (8.5 M) | (36.3 M) | 19.2 M | (10.1 M) | (5.3 M) | (5.5 M) | (4.9 M) | (5.2 M) |
| LFWD | (32.5 M) | (32.5 M) | (32.5 M) | (32.5 M) | (32.5 M) | (32.5 M) | (32.5 M) | (24.7 M) | (21.7 M) | (15.6 M) | (13 M) | (12.7 M) | (19.6 M) | (22.1 M) | (28.9 M) | (33.3 M) | (34.9 M) |
Biomerica and related stocks such as STRATA Skin Sciences, Inspira Technologies Oxy, and PAVmed Inc Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Biomerica financial statement analysis. It represents the amount of money remaining after all of Biomerica operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Biomerica Competitive Analysis
The better you understand Biomerica competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Biomerica's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Biomerica's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Biomerica Competition Performance Charts
Five steps to successful analysis of Biomerica Competition
Biomerica's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Biomerica in relation to its competition. Biomerica's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Biomerica in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Biomerica's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Biomerica, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Biomerica position
In addition to having Biomerica in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Online Gaming Thematic Idea Now
Online Gaming
Companies that are involved in the building and marketing of online gaming-related products. The Online Gaming theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Online Gaming Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Biomerica Correlation with its peers. For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomerica. Projected growth potential of Biomerica fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Biomerica assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (1.53) | Revenue Per Share | Quarterly Revenue Growth (0.24) | Return On Assets | Return On Equity |
Understanding Biomerica requires distinguishing between market price and book value, where the latter reflects Biomerica's accounting equity. The concept of intrinsic value - what Biomerica's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Biomerica's price substantially above or below its fundamental value.
It's important to distinguish between Biomerica's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Biomerica should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Biomerica's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.